全文获取类型
收费全文 | 740篇 |
免费 | 53篇 |
出版年
2022年 | 5篇 |
2021年 | 16篇 |
2020年 | 9篇 |
2019年 | 9篇 |
2018年 | 12篇 |
2017年 | 13篇 |
2016年 | 17篇 |
2015年 | 31篇 |
2014年 | 30篇 |
2013年 | 44篇 |
2012年 | 63篇 |
2011年 | 51篇 |
2010年 | 29篇 |
2009年 | 34篇 |
2008年 | 50篇 |
2007年 | 50篇 |
2006年 | 38篇 |
2005年 | 29篇 |
2004年 | 34篇 |
2003年 | 48篇 |
2002年 | 30篇 |
2001年 | 8篇 |
2000年 | 4篇 |
1999年 | 11篇 |
1998年 | 11篇 |
1997年 | 5篇 |
1996年 | 6篇 |
1995年 | 10篇 |
1994年 | 4篇 |
1993年 | 6篇 |
1992年 | 6篇 |
1990年 | 6篇 |
1989年 | 4篇 |
1988年 | 3篇 |
1987年 | 6篇 |
1986年 | 5篇 |
1985年 | 5篇 |
1984年 | 6篇 |
1983年 | 8篇 |
1982年 | 4篇 |
1981年 | 7篇 |
1974年 | 2篇 |
1973年 | 2篇 |
1958年 | 1篇 |
1957年 | 1篇 |
1948年 | 1篇 |
1936年 | 2篇 |
1933年 | 1篇 |
1930年 | 1篇 |
1924年 | 1篇 |
排序方式: 共有793条查询结果,搜索用时 203 毫秒
31.
32.
Cellular and humoral responses to collagen-polyvinylpyrrolidone administered during short and long periods in humans 总被引:2,自引:0,他引:2
Furuzawa-Carballeda J Rojas E Valverde M Castillo I Diaz de León L Krötzsch E 《Canadian journal of physiology and pharmacology》2003,81(11):1029-1035
Collagen, particularly type I, and its related derivatives have been extensively employed in many areas of pharmacology. The present study was performed to determine the safety of collagen-polyvinylpyrrolidone (collagen-PVP) by in vitro and in vivo studies. Sera and peripheral blood cells from healthy donors without treatment and patients treated with collagen-PVP were evaluated. We observed that the biodrug does not stimulate lymphoproliferation or DNA damage in vitro, nor does it induce human anti-porcine type I collagen or anti-collagen-PVP antibodies in vivo. Furthermore, no hepatic or renal metabolic dysfunctions were observed when collagen-PVP was administered by intradermal or intramuscular routes in short- or long-term treatments. In conclusion, the present work shows that no cellular damage or immunological adverse effects (cellular and humoral) occurred during collagen-PVP treatment, even after more than 400 weeks of consecutive administrations. 相似文献
33.
34.
Stearne LE Schiffelers RM Smouter E Bakker-Woudenberg IA Gyssens IC 《Biochimica et biophysica acta》2002,1561(1):91-97
The biodistribution of long-circulating PEG-liposomes in a subcutaneous mouse model of established mixed infection abscesses was investigated to assess their possible role as drug carriers in the treatment of small, undrainable intra-abdominal abscesses. There was a 10-30-fold greater localisation of (67)Ga-labelled PEG-liposomes in abscesses compared to uninfected normal skin samples. Over 3% of the injected dose (ID) of liposomes was present in the abscesses 24 h after liposome administration in contrast to 0.1% in normal skin sections. The percentage ID present in the liver, spleen and kidneys was 17%, 4% and 2% per organ respectively. Five days after liposome injection, 2% ID could still be recovered from the abscesses. Using colloidal gold-labelled PEG-liposomes, it was shown that there was a 4-fold greater density of liposome clusters in the subcutaneous tissue surrounding the capsule than in the core of the abscesses. The clusters within the abscesses were distributed evenly. We conclude that PEG-liposomes localise to a significant degree at the infection focus in our mouse model and may provide a new approach to the antimicrobial treatment of intra-abdominal abscesses. 相似文献
35.
Talledo M Rivera IN Lipp EK Neale A Karaolis D Huq A Colwell RR 《Environmental microbiology》2003,5(5):350-354
A Vibrio cholerae bacteriophage, family Myoviridae, was isolated from seawater collected from the coastal water of Lima, Peru. Genome size was estimated to be 29 kbp. The temperate phage was specific to V. cholerae and infected 12/13 V. cholerae O1 strains and half of the four non-O1/non-O139 strains tested in this study. Vibrio cholerae O139 strains were resistant to infection and highest infection rates were obtained in low nutrient media amended with NaCl or prepared using seawater as diluent. 相似文献
36.
Vervelde L Bakker N Kooyman FN Cornelissen AW Bank CM Nyame AK Cummings RD van Die I 《Glycobiology》2003,13(11):795-804
Lambs respond to vaccination against bacteria and viruses but have a poor immunological response to nematodes. Here we report that they are protected against the parasitic nematode Haemonchus contortus after vaccination with excretory/secretory (ES) glycoproteins using Alhydrogel as an adjuvant. Lambs immunized with ES in Alhydrogel and challenged with 300 L3 larvae/kg body weight had a reduction in cumulative egg output of 89% and an increased percentage protection of 54% compared with the adjuvant control group. Compared to the adjuvant dimethyl dioctadecyl ammonium bromide, Alhydrogel induced earlier onset and significantly higher ES- specific IgG, IgA, and IgE antibody responses. In all vaccinated groups a substantial proportion of the antibody response was directed against glycan epitopes, irrespective of the adjuvant used. In lambs vaccinated with ES in Alhydrogel but not in any other group a significant increase was found in antibody levels against the GalNAcbeta1,4 (Fucalpha1,3)GlcNAc (fucosylated LacdiNAc, LDNF) antigen, a carbohydrate antigen that is also involved in the host defense against the human parasite Schistosoma mansoni. In lambs the LDNF-specific response increased from the first immunization onward and was significantly higher in protected lambs. In addition, an isotype switch from LDNF-specific IgM to IgG was induced that correlated with protection. These data demonstrate that hyporesponsiveness of lambs to H. contortus can be overcome by vaccination with ES glycoproteins in a strong T-helper 2 type response-inducing aluminum adjuvant. This combination generated high and specific antiglycan antibody responses that may contribute to the vaccination-induced protection. 相似文献
37.
38.
The dendritic cell-specific C-type lectin DC-SIGN is a receptor for Schistosoma mansoni egg antigens and recognizes the glycan antigen Lewis x 总被引:14,自引:0,他引:14
van Die I van Vliet SJ Nyame AK Cummings RD Bank CM Appelmelk B Geijtenbeek TB van Kooyk Y 《Glycobiology》2003,13(6):471-478
Schistosoma mansoni soluble egg antigens (SEAs) are crucially involved in modulating the host immune response to infection by S. mansoni. We report that human dendritic cells bind SEAs through the C-type lectin dendritic cell-specific ICAM-3-grabbing nonintegrin (DC-SIGN). Monoclonal antibodies against the carbohydrate antigens Lewisx (Lex) and GalNAcbeta1-4(Fucalpha1-3)GlcNAc (LDNF) inhibit binding of DC-SIGN to SEAs, suggesting that these glycan antigens may be critically involved in binding. In a solid-phase adhesion assay, DC-SIGN-Fc binds polyvalent neoglycoconjugates that contain the Lex antigen, whereas no binding was observed to Galbeta1-4GlcNAc, and binding to neoglycoconjugates containing only alpha-fucose or oligosaccharides with a terminal alpha1-2-linked fucose is low. These data indicate that binding of DC-SIGN to Lex antigen is fucose-dependent and that adjacent monosaccharides and/or the anomeric linkage of the fucose are important for binding activity. Previous studies have shown that DC-SIGN binds HIV gp120 that contains high-mannose-type N-glycans. Site-directed mutagenesis within the carbohydrate recognition domain (CRD) of DC-SIGN demonstrates that amino acids E324 and E347 are involved in binding to HIV gp120, Lex, and SEAs. By contrast, mutation of amino acid Val351 abrogates binding to SEAs and Lex but not HIV gp120. These data suggest that DC-SIGN recognizes these ligands through different (but overlapping) regions within its CRD. Our data imply that DC-SIGN not only is a pathogen receptor for HIV gp120 but may also function in pathogen recognition by interaction with the carbohydrate antigens Lex and possibly LDNF, which are found on important human pathogens, such as schistosomes and the bacterium Helicobacter pylori. 相似文献
39.
40.
Anita Kloss-Brandst?tter Hansi Weissensteiner Gertraud Erhart Georg Sch?fer Lukas Forer Sebastian Sch?nherr Dominic Pacher Christof Seifarth Andrea St?ckl Liane Fendt Irma Sottsas Helmut Klocker Christian W. Huck Michael Rasse Florian Kronenberg Frank R. Kloss 《PloS one》2015,10(8)